What are the 2026 adult hypertension guidelines, including treatment thresholds, target blood pressure goals, lifestyle modification recommendations, and first‑line pharmacologic options?

2026 Adult Hypertension Guidelines

Blood Pressure Classification

The 2025 AHA/ACC guidelines define hypertension as blood pressure ≥130/80 mmHg, confirmed by out-of-office measurements. 1, 2, 3

• Normal: <120/80 mmHg 1, 2, 3
• Elevated: 120–129/<80 mmHg 2, 3
• Stage 1 Hypertension: 130–139/80–89 mmHg 1, 2, 3
• Stage 2 Hypertension: ≥140/90 mmHg 1, 2, 3

---

Diagnostic Confirmation

• Confirm hypertension with home blood pressure monitoring ≥135/85 mmHg OR 24-hour ambulatory monitoring ≥130/80 mmHg after office readings show ≥130/85 mmHg. 1, 3
• Use validated automated upper-arm cuff devices with appropriately sized cuffs. 1, 3
• Measure both arms simultaneously at the first visit and use the arm with the higher reading for all subsequent measurements. 1, 3
• Do not rely on cuffless devices (smartwatches) due to poor accuracy. 1, 2, 3

---

Treatment Targets

The universal blood pressure target for most adults is <130/80 mmHg, with encouragement toward systolic <120 mmHg when feasible in high-risk patients. 1, 2, 3

High-Risk Patients

• For adults with 10-year cardiovascular risk ≥7.5%, established CVD, CKD, diabetes, or target-organ damage, aim for systolic BP <130 mmHg and encourage <120 mmHg when feasible; diastolic <80 mmHg. 3

Special Populations

• Patients >80 years or frail: Individualize targets; <140/90 mmHg is acceptable, though <130/80 mmHg remains the overarching goal. 1, 3
• Patients with diabetes or CKD: Maintain the stricter target of <130/80 mmHg. 1
• Achieve target BP within 3 months of therapy initiation. 1, 3
• Aim for a minimum reduction of 20 mmHg systolic and 10 mmHg diastolic from baseline. 1, 3

---

Lifestyle Modifications (Class I Recommendation)

All adults with elevated BP or hypertension must adopt comprehensive lifestyle changes before or alongside pharmacotherapy. 1, 2, 3

• Sodium restriction: Limit intake to <2 g/day (≈5 g salt). 1
• Potassium supplementation: Daily intake ≥3.5 g. 1
• Weight reduction: Target BMI 18.5–24.9 kg/m² and waist circumference ≤102 cm (men) or ≤88 cm (women); each kilogram lost lowers systolic BP by approximately 1 mmHg. 1
• Physical activity: 30–60 minutes of moderate-intensity aerobic exercise on 4–7 days per week. 1
• Dietary pattern: Follow DASH or Mediterranean diet emphasizing fruits, vegetables, low-fat dairy, whole grains, plant proteins, and low saturated fat. 1, 2
• Alcohol limitation: ≤14 standard drinks/week for men and ≤9 drinks/week for women. 1
• Stress management: Implement effective techniques. 2, 3

---

Pharmacologic Therapy Initiation

Immediate Initiation (Start Medication Now)

Begin drug therapy immediately for:

• Stage 2 hypertension (≥160/100 mmHg) regardless of cardiovascular risk. 1, 3
• Stage 1 hypertension (140–159/90–99 mmHg) when ANY of the following are present: 1, 2, 3
  • Clinical cardiovascular disease
  • Prior stroke
  • Chronic kidney disease
  • Diabetes mellitus
  • Age 50–80 years
  • 10-year atherosclerotic cardiovascular disease risk ≥7.5%

Delayed Initiation (After 3–6 Months of Lifestyle Therapy)

• For low-to-moderate risk patients with stage 1 hypertension (BP ≥130/80 mmHg and 10-year risk <7.5%), defer medication for 3–6 months of lifestyle modification; initiate only if BP remains elevated. 1, 2, 3

---

First-Line Pharmacologic Therapy

Stage 2 Hypertension (≥140/90 mmHg)

Initiate a single-pill fixed-dose combination of two first-line agents from different classes. 1, 2, 3

• This strategy improves medication adherence, shortens time to BP control, and reduces side effects by allowing lower individual drug doses. 1
• Do NOT combine an ACE inhibitor with an ARB unless a compelling indication exists. 1, 2

Stage 1 Hypertension: Race-Based Approach

Non-Black patients: 1, 3

1. Begin with low-dose ACE inhibitor or ARB
2. Add a dihydropyridine calcium-channel blocker (DHP-CCB)
3. Titrate to full doses
4. Add a thiazide/thiazide-like diuretic
5. Consider spironolactone if uncontrolled

Black patients: 1, 3

1. Begin with low-dose ARB + DHP-CCB OR DHP-CCB + thiazide combination
2. Titrate to full doses
3. Add the remaining class (diuretic or ACE inhibitor/ARB)
4. Consider spironolactone if uncontrolled

First-Line Drug Classes (Equally Recommended)

• Thiazide or thiazide-like diuretics (chlorthalidone, hydrochlorothiazide, indapamide) 1, 2
• Long-acting dihydropyridine calcium-channel blockers (amlodipine, nifedipine) 1, 2
• ACE inhibitors (enalapril, lisinopril, ramipril) 1, 2
• Angiotensin-II receptor blockers (candesartan, losartan, valsartan) 1, 2

---

Treatment Intensification Algorithm

Step 3 – Triple Therapy

• Add a third agent from the remaining major class (typically RAS blocker + CCB + thiazide) at full doses. 1, 2

Step 4 – Resistant Hypertension

• First add spironolactone 25–50 mg daily as the preferred fourth agent. 1, 2
• Alternatives include eplerenone, amiloride, doxazosin, or vasodilating β-blockers (labetalol, carvedilol, nebivolol). 1, 2

Step 5 – Refractory Hypertension

• Consider hydralazine, centrally acting agents (clonidine), α-blockers, or referral to a hypertension specialist. 1, 2
• Reserve minoxidil for truly refractory cases due to significant side effects. 1, 2

---

Monitoring and Follow-Up

• Reassess BP control at 3 months to verify target achievement. 1, 3
• Home BP monitoring combined with team-based care improves control rates. 2, 3
• Verify medication adherence before escalating therapy. 1, 3
• Refer to a hypertension specialist if BP remains uncontrolled despite maximally tolerated triple therapy. 1, 3

---

Critical Pitfalls to Avoid

• Do not use β-blockers as first-line therapy except in patients <60 years or those with compelling indications (coronary artery disease, heart failure). 1
• Do not routinely combine an ACE inhibitor with an ARB; this increases adverse events without added benefit. 1, 2
• Do not delay treatment in high-risk stage 1 hypertension; immediate pharmacotherapy reduces cardiovascular events. 1
• Avoid excessive BP lowering in patients >80 years, as it raises the risk of falls, syncope, and acute kidney injury. 1
• Do not manage severe hypertension (>180/120 mmHg) without acute target-organ damage in the emergency department; manage outpatient with timely initiation or intensification of oral antihypertensive therapy. 2, 3

---

Team-Based Care

• A multidisciplinary team (physicians, pharmacists, nurse practitioners, nurses, physician assistants, dietitians, community health workers) effectively addresses medication access and structural barriers to achieve hypertension control. 2, 3